
THE SPECTRUM AND FREQUENCY OF CYSTIC FIBROSIS MUTATIONS IN ALBANIAN PATIENTS Kasmi I, Kasmi G, Basholli B, Sefa HS, Vevecka E *Corresponding Author: Ass. Prof. Irena Kasmi, Pediatric Clinic, Pediatric Department, University
Hospital Center “Mother Teresa”, Tirana, Albania. Address: Street Dibra 372, Tirana, Albania.
Tel: + 355 67 2066175, E-mail: irenakasmi@hotmail.com page: 31 download article in pdf format
|
Abstract
BACKGROUND
Cystic fibrosis (CF) is a genetic disease character-
ized by a wide spectrum of severity, resulting from the
inheritance of a mutant allele of the gene for cystic fibrosis
transmembrane conductance regulator (CFTR). The aim of
the study was to present a CFTR mutation analysis among
the Albanian population and to identify rare variants.
METHODS
We identified CFTR mutations in a representative
cohort of CF patients comprising of Albanian patients
and some Kosovo patients followed up by the Department
of Pediatrics at the University Hospital Center “Mother
Theresa” (UHCMT). Compiled clinical and genotypic
data include 133 previously analyzed patients, of whom
116 have two identified mutations, 6 have only one known
mutation, and 11 are unexamined.
RESULTS
The most frequent mutation is F508del (83.19%),
followed by 621+1G>T (2.45%). Other mutations identi-
fied in decrease order are E822X, G85E, G542X, R1066C,
R1070Q, R1158X, G1349D, N1303K, S466X, 1811+1G-
>C, E831X, CFTRdele2,3(21kb).
CONCLUSIONS
The data suggest that most of these patients can
benefit from new modulatory therapies targeting CFTR
mutations, translating to very hopeful prospects for these
patients.
The Albanian population would benefit from Cystic
Fibrosis neonatal screening, since outcomes can be im-
proved through early diagnosis.
|
|
|
|



 |
Number 27 VOL. 27 (2), 2024 |
Number 27 VOL. 27 (1), 2024 |
Number 26 Number 26 VOL. 26(2), 2023 All in one |
Number 26 VOL. 26(2), 2023 |
Number 26 VOL. 26, 2023 Supplement |
Number 26 VOL. 26(1), 2023 |
Number 25 VOL. 25(2), 2022 |
Number 25 VOL. 25 (1), 2022 |
Number 24 VOL. 24(2), 2021 |
Number 24 VOL. 24(1), 2021 |
Number 23 VOL. 23(2), 2020 |
Number 22 VOL. 22(2), 2019 |
Number 22 VOL. 22(1), 2019 |
Number 22 VOL. 22, 2019 Supplement |
Number 21 VOL. 21(2), 2018 |
Number 21 VOL. 21 (1), 2018 |
Number 21 VOL. 21, 2018 Supplement |
Number 20 VOL. 20 (2), 2017 |
Number 20 VOL. 20 (1), 2017 |
Number 19 VOL. 19 (2), 2016 |
Number 19 VOL. 19 (1), 2016 |
Number 18 VOL. 18 (2), 2015 |
Number 18 VOL. 18 (1), 2015 |
Number 17 VOL. 17 (2), 2014 |
Number 17 VOL. 17 (1), 2014 |
Number 16 VOL. 16 (2), 2013 |
Number 16 VOL. 16 (1), 2013 |
Number 15 VOL. 15 (2), 2012 |
Number 15 VOL. 15, 2012 Supplement |
Number 15 Vol. 15 (1), 2012 |
Number 14 14 - Vol. 14 (2), 2011 |
Number 14 The 9th Balkan Congress of Medical Genetics |
Number 14 14 - Vol. 14 (1), 2011 |
Number 13 Vol. 13 (2), 2010 |
Number 13 Vol.13 (1), 2010 |
Number 12 Vol.12 (2), 2009 |
Number 12 Vol.12 (1), 2009 |
Number 11 Vol.11 (2),2008 |
Number 11 Vol.11 (1),2008 |
Number 10 Vol.10 (2), 2007 |
Number 10 10 (1),2007 |
Number 9 1&2, 2006 |
Number 9 3&4, 2006 |
Number 8 1&2, 2005 |
Number 8 3&4, 2004 |
Number 7 1&2, 2004 |
Number 6 3&4, 2003 |
Number 6 1&2, 2003 |
Number 5 3&4, 2002 |
Number 5 1&2, 2002 |
Number 4 Vol.3 (4), 2000 |
Number 4 Vol.2 (4), 1999 |
Number 4 Vol.1 (4), 1998 |
Number 4 3&4, 2001 |
Number 4 1&2, 2001 |
Number 3 Vol.3 (3), 2000 |
Number 3 Vol.2 (3), 1999 |
Number 3 Vol.1 (3), 1998 |
Number 2 Vol.3(2), 2000 |
Number 2 Vol.1 (2), 1998 |
Number 2 Vol.2 (2), 1999 |
Number 1 Vol.3 (1), 2000 |
Number 1 Vol.2 (1), 1999 |
Number 1 Vol.1 (1), 1998 |
|
|